BioSpace News Archive

Aadi Bioscience, Inc. (NASDAQ: AADI) today announced that it will host a conference call and live webcast on Wednesday, November 8, 2023 at 8:30 am ET (5:30 am PT) to report third quarter 2023 financial results and provide an operational update.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today reported its third quarter 2023 financial results.

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 61,000 shares of Akebia’s common stock on October 31, 2023, as an inducement material to such employee entering into employment with Akebia.

Trevi Therapeutics, Inc. announced that senior management will host a conference call and live audio webcast on Thursday, November 9, 2023, at 4:30 p.m. ET, to provide a corporate update and review the Company’s financial results for the third quarter ended September 30, 2023.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the latest STRIKE-PE data evaluating Penumbra’s Indigo® Aspiration System with Lightning™.

BioMarin Pharmaceutical Inc. announced financial results for the nine months and third quarter ended September 30, 2023.

Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and AbCellera (Nasdaq: ABCL) today announced a multi-year, multi-program partnership to discover, develop, and commercialize potentially first-in-class treatments for patients with cancer.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company, reported its financial results for the quarter ended September 30, 2023 and updated its financial guidance for the year ending December 31, 2023.

Amsterdam, the Netherlands – argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that members of management will participate in several upcoming investor conferences in November.

Spexis AG announced that Hernan Levett, currently Chief Financial Officer, has decided to pursue a new career opportunity outside the company.